Dysregulated mitochondrial function in placenta is thought to play a key role in the pathogenesis of GDM and its complications (107). Thus, increased PGC1-α promoter methylation and subsequent decreased PGC1-α expression may lead to mitochondrial dysfunction, oxidative stress, insulin resistance and GDM. The gene discussed is PPARGC1A; the disease is Insulin resistance.